Cargando…

Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective

BACKGROUND: Based on immunologic phenotypes underlying asthma, use of monoclonal antibody based therapies is becoming the new standard of care for severe, corticosteroid refractory clinical symptoms. Patients may qualify for one or more of these targeted treatments, based on clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeimy, Samira, Tsoulis, Michael William, Hachey, Julie, Kim, Harold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249851/ https://www.ncbi.nlm.nih.gov/pubmed/30479629 http://dx.doi.org/10.1186/s13223-018-0301-6

Ejemplares similares

Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective
por: Zhu, Rongbo, et al.
Publicado: (2020)

Telemedicine in allergy/immunology in the era of COVID-19: a Canadian perspective
por: Edgerley, Sarah, et al.
Publicado: (2022)

Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
por: Jeimy, Samira, et al.
Publicado: (2019)

Geographical discrepancy in oral food challenge utilization based on Canadian billing data
por: El Baba, Ala, et al.
Publicado: (2023)

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

An emerging allergen: Cannabis sativa allergy in a climate of recent legalization
por: Jackson, Bradley, et al.
Publicado: (2020)

Dual Monoclonal Antibody Therapy for a Severe Asthma Patient
por: Domingo, Christian, et al.
Publicado: (2020)

The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
por: Zamagni, Elena, et al.
Publicado: (2020)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
por: Ghassemian, Arian, et al.
Publicado: (2021)

Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected?
por: Ucciferri, Claudio, et al.
Publicado: (2023)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
por: Rees, Jennifer, et al.
Publicado: (2017)

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control
por: de Carvalho-Pinto, Regina Maria, et al.
Publicado: (2017)

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective
por: Berghea, Elena Camelia, et al.
Publicado: (2021)

Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature
por: Kovaltchouk, Uliana, et al.
Publicado: (2023)

Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
por: Deng, Zhenan, et al.
Publicado: (2023)

Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy
por: Torre, Alessandro, et al.
Publicado: (2020)

The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
por: Matucci, Andrea, et al.
Publicado: (2018)

Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
por: Casas-Maldonado, Francisco, et al.
Publicado: (2023)

Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
por: Perez, Norma, et al.
Publicado: (2004)

Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)
por: Tebbey, Paul W, et al.
Publicado: (2015)

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Use of the World Health Organization’s Medical Eligibility Criteria for Contraceptive Use Guidance in sub-Saharan African Countries: A Cross-Sectional Study
por: Chen, Melissa J, et al.
Publicado: (2016)

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
por: D’Amato, Gennaro, et al.
Publicado: (2014)

Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series
por: Taillé, Camille, et al.
Publicado: (2013)

A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
por: Agumadu, Vivian C, et al.
Publicado: (2018)

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells
por: Freund, Guillaume, et al.
Publicado: (2013)

Mitochondria-Specific Monoclonal Antibodies in Eggs and Embryos of the Ascidian Halocynthia roretzi
por: Baek, Yong Han, et al.
Publicado: (2017)

A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies
por: Owen, Carolyn, et al.
Publicado: (2022)

Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity
por: Edgerley, Sarah, et al.
Publicado: (2022)

Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology
por: Jeimy, Samira, et al.
Publicado: (2020)

Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
por: Morobeid, Heba, et al.
Publicado: (2021)

Ventilation heterogeneity in children with severe asthma
por: Nuttall, Amy G., et al.
Publicado: (2021)

Elucidation of Critical Epitope of Anti-Rat Podoplanin Monoclonal Antibody PMab-2
por: Furusawa, Yoshikazu, et al.
Publicado: (2018)

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
por: Bu, Melissa T., et al.
Publicado: (2022)

Expression of a recombinant ASFV P30 protein and production of monoclonal antibodies
por: Liberti, Rosario, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_it98jdiht11tghrhn6gs3fr3fq